ADVFN - Advanced Financial Network.
HOME» NASDAQ » I » ILMN Stock Price » ILMN Stock News

Illumina Share News

 Illumina (mm) Stock Price
ILMN Stock Price
 Illumina (mm) Stock Chart
ILMN Stock Chart
 Illumina (mm) Stock News
ILMN Stock News
 Illumina (mm) Company Information
ILMN Company Information
 Illumina (mm) Stock Trades
ILMN Stock Trades

Roche Sends Second Letter To Illumina Shareholders

ZURICH -(Dow Jones)- Roche Holding Holding AG (ROG.VX) Wednesday sent a second letter to shareholders of takeover target Illumina Inc. (NASDAQ: ILMN) urging them to tender their shares into Roche's increased offer and vote for Roche's independent director nominees at the U.S. gene sequencing company's AGM later this month. MAIN FACTS: - Roche raised its offer to $51 per Illumina share on March 29. - Letter from Roche Chief Executive Severin Schwan says Illumina board has been unwilling to engage in meaningful discussions "despite our willingness to pay a substantial price for your shares." - "After Roche's multiple attempts to engage were rebuffed, we were left with no choice but to bring our offer directly to you, Illumina's shareholders, and provide you with the opportunity to act in your own financial interests," Schwan writes. - "At $51.00, the fiduciary responsibilities of the board and management of Illumina require engagement," Schwan writes. - " The best way for you, as a shareholder, to obtain value certainty today for your shares is to vote for engagement. Tender your shares into our offer and vote for Roche's independent director nominees and other proposals at the 2012 Illumina Annual Meeting to be held on 18 April 2012." - Illumina shares closed Tuesday up 0.6% at $52. -Zurich Bureau, Dow Jones Newswires, +41 43 443 80 47; zurichdjnews@dowjones.com

Stock News for Illumina (ILMN)
DateTimeHeadline
02/03/201610:17:53Amended Statement of Ownership (sc 13g/a)
02/02/201618:40:00Illumina Posts 32% Decline in Profit
02/02/201616:36:32Current Report Filing (8-k)
02/02/201616:32:00Illumina Reports Financial Results for Fourth Quarter and Fiscal...
02/01/201616:42:40Current Report Filing (8-k)
02/01/201606:30:00Illumina Signs Multiple Biobank Deals
01/28/201618:11:12Statement of Changes in Beneficial Ownership (4)
01/28/201608:31:59Current Report Filing (8-k)
01/28/201606:30:00Illumina Appoints Dr. Frances Arnold to Its Board of Directors
01/21/201618:34:29Statement of Changes in Beneficial Ownership (4)
01/19/201606:30:00Illumina to Announce Fourth Quarter and Fiscal Year 2015 Financial...
01/14/201618:03:35Statement of Changes in Beneficial Ownership (4)
01/14/201612:04:17Current Report Filing (8-k)
01/11/201614:31:00Bio-Rad and Illumina to Co-Develop Comprehensive Solution for...
01/11/201614:29:00Illumina Extends Genomics Portfolio
01/10/201621:20:00Illumina Launches Firm to Pursue Gene-Based Cancer Blood Test
01/10/201617:29:00Illumina Forms New Company to Enable Early Cancer Detection via...
01/08/201616:05:00Illumina to Host Investor Call on Sunday, January 10, 2016
01/08/201608:32:00Illumina Files Patent Suit Against Premaitha's Customer in Poland
01/07/201616:05:00Illumina Files Two Patent Infringement Suits in Europe for Infringement...

Illumina and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad